-
Chemistry
C18
-
Separation Mode
Reversed Phase
-
Particle Substrate
Hybrid
-
pH Range Min
1 pH
-
pH Range Max
12 pH
-
Endcapped
Yes
-
Silanol Activity
Low
-
Particle Shape
Spherical
-
Particle Size
2.5 µm
-
Endfitting Type
Waters
-
Pore Size
130 Å
-
QC Tested
Oligonucleotide
-
Format
Method Validation Kit
-
Surface Area
185
-
System
UHPLC
-
Particle Technology
BEH
-
USP Classification
L1
-
Inner Diameter
4.6 mm
-
Length
50 mm
-
Carbon Load
12 %
-
UNSPSC
41115709
-
Application
Oligonucleotide, Gene Therapeutics
-
Brand
XBridge
-
Product Type
Column Kits
-
Units per Package
3 pk
XBridge Oligonucleotide BEH C18 Method Validation Kit, 130Å, 2.5 µm, 4.6 mm X 50 mm, 3/pk
Бренд: Waters
The reproducibility of a chromatographic column has a critical impact on the long-term reliability and robustness of an analytical method, and its reproducibility lies completely outside the user’s control. With exceptional batch-to-batch and column-to-column reproducibility, Waters well-established particle and column manufacturing process control provides confidence in the long-term reliability of your analytical method. ACQUITY OST C18, 135A, 2.5um Method Validation Kit includes three batches of chromatographic media [derived from different base particles] to judge the quality, reliability, and consistency of your chromatographic method. Each batch of selected ACQUITY OST C18, 135A, 2.5um chemistry is specifically QC tested with a mixture of synthetic oligonucleotides to help ensure consistent performance.






























